California 2025-2026 Regular Session

California Assembly Bill AB957

Introduced
2/20/25  
Refer
3/28/25  
Report Pass
4/8/25  
Refer
4/8/25  
Report Pass
4/24/25  
Refer
4/29/25  
Refer
5/7/25  
Report Pass
5/23/25  
Engrossed
6/2/25  

Caption

Cigarette and tobacco products: retail sale: pharmacies.

Impact

If enacted, this legislation is expected to alter the landscape of tobacco product availability within the state significantly. Pharmacies, typically perceived as health-centric establishments, will no longer be able to sell tobacco products, effectively removing a point of access for consumers. Additionally, this bill will prevent the Department of Tax and Fee Administration from issuing licenses to pharmacies for the sale of these products. Given that violations will result in misdemeanor charges, the bill establishes a state-mandated local program pertaining to enforcement and compliance.

Summary

Assembly Bill 957, introduced by Assembly Member Ortega, seeks to amend the existing regulations regarding the sale of cigarettes and tobacco products by prohibiting pharmacies from engaging in their retail sale. This law arises from the provisions outlined in the Cigarette and Tobacco Products Licensing Act of 2023, which mandates that retailers must hold an appropriate license from the State Board of Equalization to sell these products. The intent behind AB 957 is to mitigate access to tobacco products through pharmacies, which are often associated with health and wellness, thus reinforcing public health efforts to reduce tobacco consumption.

Sentiment

The sentiment surrounding AB 957 appears to be largely positive among proponents of public health, as the bill is viewed as a progressive step towards reducing tobacco use within vulnerable populations. Supporters argue that by removing the sale of cigarettes from pharmacies, it aligns the operations of these healthcare providers with their fundamental goal of promoting health. Conversely, there may be some contention among retail pharmacies, as this segment of the industry relies on a diverse product offering, and the restriction could potentially impact their revenue streams.

Contention

Notable points of contention include concerns raised by retail pharmacy advocates who fear that the prohibition on cigarette sales may lead to revenue losses. Additionally, the wording around state reimbursement for local costs associated with the enforcement of this bill has sparked discussions among legislators. The bill clarifies that no state reimbursement will be required due to the nature of the imposed restrictions and the definitions related to crime under state law. This aspect has led to debates on the financial ramifications for local agencies involved in enforcement.

Companion Bills

No companion bills found.

Similar Bills

CA SB491

Cigarette and Tobacco Products Licensing Act of 2003.

CA AB1107

Cigarette and Tobacco Products Licensing Act of 2003: nitrous oxide: licensure.

CA SB152

Transactions and use taxes: County of Sonoma.

CA AB180

Medi-Cal.

CA SB395

Excise tax: electronic cigarettes: Health Careers Opportunity Grant Program: Small and Rural Hospital Relief Program.

CA SB424

Tobacco products: single-use and multiuse components.

NJ A2797

Revises requirements for sale of tobacco and vapor products; increases penalties for prohibited sales; increases fees for cigarette and vapor business licensure.

NJ S1039

Revises requirements for sale of tobacco and vapor products; increases penalties for prohibited sales; increases fees for cigarette and vapor business licensure.